1.Gadient, RA, Otten, UH. Interleukin-6 (IL-6) – a moleculen with both beneficial and destructive potentials. Prog Neurobiol 1997;52:379–390.
2.Hopkins, SJ, Rothwell, NJ. Cytokines and the nervous system I: expression and recognition. Trends Neurosci 1995;18:83–88.
3.Van Wagoner, NJ, Benveniste, EN. Interleukin-6 expression and regulation in astrocytes. J Neuroimmunol 1999;100:124–139.
4.Kaplin, AI, Deshpande, DM, Scott, Eet al. IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis. J Clin Invest 2005;115:2731–2741.
5.Brisby, H, Olmarker, K, Larsson, Ket al. Proinflammatory cytokines in cerebrospinal fluid and serum in patients with disc herniation and sciatica. Eur Spine J 2002;11:62–66.
6.Kanemoto, M. Immunohistochemical study of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in human intervertebral disk. Spine 1996;21:1–8.
7.Tuna, M, Polat, S, Ennan, Tet al. Effect of anti-rat interleukin-6 antibody after spinal cord injury in the rat: inducible nitric oxide synthase expression, sodium-and potassium-activated, magnesium-dependent adenosine-5’-triphosphatase and superoxide dismutase activation, and ultrastmetural changes. J Neurosurg 2001;96:64–73.
8.Neuhuber, B, Timothy Himes, B, Shumsky, JS, Gallo, G, Fischer, I. Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations. Brain Res 2005;1035:73–85.
9.Sallmann, S, Juttler, E, Prinz, Set al. Induction of interleukin-6 by depolarization of neurons. J Neurosci 2000;20:8637–8642.
10.Jones, TB, McDaniel, EE, Popovich, PG. Inflammatory-mediated injury and repair in the traumatically injured spinal cord. Curr Pharm Des 2005;11:1223–1236.
11.Carlson, NG, Wieqqel, WA, Chen, J, Bacchi, A, Roqers, SW, Gahring, LC. Inflammatory cytokines IL-1alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways. J Immunol 1999;163:3963–3968.
12.Liu, Z, Qiu, YH, Li, Bet al. Neuroprotection of interleukin-6 against NMDA-induced apoptosis and its signal-transduction mechanisms. Neurotox Res 2011;11:484–495.
13.Pizzi, M, Sarnico, I, Boroni, F, Benarese, M, Dreano, M, Garotta, G. Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/IL-6 fusion protein in organotypic hippocampal slices. Mol Cell Neurosci 2004;25:301–311.
14.Wang, XQ, Peng, YP, Lu, JHet al. Neuro-protection of interleukin-6 against NMDA attack and its signal-transduction by JAK and MAPK. Neurosci Lett 2009;450:122–126.
15.Hodgkin, AL, Huxley, AF. A quantitative description of membrane current and its application to induction and excitation in nerve. J Physiol 1952;117:500–544.
16.Hille, B. Ion Channels of Excitable Membranes. Sunderland, MA: Sinauer Associates Inc, 2001.
17.Zhou, C, Qi, C, Zhao, Jet al. Interleukin-1β inhibits voltage-gated sodium currents in a time- and dose-dependent manner in cortical neurons. Neurochem Res 2001;31:1116–1123.
18.Goldfarb, M, Schoorlemmer, J, Williams, Aet al. Fibroblast growth factor homologous factors control neuronal excitability through modulation of voltage-gated sodium channels. Neuron 2007;55:449–463.
19.Rush, AM, Dib-Hajj, SD, Liu, S, Cummins, TR, Black, JA, Waxman, SG. A single sodium channel mutation produces hyper-or hypoexcitability in different types of neurons. Proc Natl Acad Sci 2006;103:8245–8250.
20.Hains, BC, Saab, CY, Klein, JPet al. Altered sodium channel expression in second-order spinal sensory neurons contributes to pain after peripheral nerve injury. J Neurosci 2004;23:4832–4839.
21.Momin, A, Wood, JN. Sensory neuron voltage-gated sodium channels as analgesic drug targets. Curr Opin Neurol 2008;18:383–388.
22.Deloulme, JC, Baudier, J, Sensenbrenner, M. Establishment of pure neuronal cultures from fetal rat spinal cord and proliferation of the neuronal precursor cells in the presence of fibroblast growth factor. J Neurosci Res 1991;29:499–509.
23.Nelson, TE, Ur, CL, Gruol, DL. Chronic interleukin-6 exposure alters electrophysiological properties and calcium signaling in developing cerebellar purkinje neurons in culture. J Neurophysiol 2002;88:475–486.
24.Ma, SH, Li, B, Huang, HWet al. Interleukin-6 inhibits L-type calcium channel activity of cultured cerebellar granule neurons. J Physiol Sci 2012;62:385–392.
25.Spooren, A, Kolmus, K, Laureys, Get al. Interleukin-6, a mental cytokine. J Brain Res Rev 2011;67:157–183.
26.Allan, SM, Rothwell, NJ. Inflammation in central nervous system injury. Phil Trans R Soc Lond B Biol Sci 2003;358:1669–1677.
27.Allan, SM, Rothwell, NJ. Cytokines and acute neurodegeneration. Nat Rev Neurosci 2001;2:734–744.
28.Peng, YP, Qiu, YH, Lu, JH, Wang, JJ. Interleukin-6 protects cultured cerebellar granule neurons against glutamate-induced neurotoxicity. Neurosci Lett 2005;374:192–196.
29.Yang, P, Wen, H, Ou, Set al. IL-6 promotes regeneration and functional recovery after cortical spinal tract injury by reactivating intrinsic growth program of neurons and enhancing synapse formation. Exp Neurol 2012;236:19–27.
30.Kang, MK. Kang SKInterleukin-6 induces proliferation in adult spinal cord-derived neural progenitors via the JAK2/STAT3 pathway with EGF-induced MAPK phosphorylation. Cell Prolif 2008;41:377–392.
31.Georgene, W, Anthony, N, J Philip, Met al. Serum IL-6: a candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury. J Neuroinflammation 2010;7:7–19.
32.Jabaudon, D, Scanziani, M, Gaähwiler, BH, Gerber, U. Acute decrease in net glutamate uptake during energy deprivation. Proc Natl Acad Sci 2000;97:5610–5615.
33.Nishizawa, Y. Glutamate release and neuronal damage in ischemia. Life Sci 2001;69:369–381.